189 related articles for article (PubMed ID: 30121624)
21. Discoidin domain receptor 1 (DDR1) ablation promotes tissue fibrosis and hypoxia to induce aggressive basal-like breast cancers.
Takai K; Drain AP; Lawson DA; Littlepage LE; Karpuj M; Kessenbrock K; Le A; Inoue K; Weaver VM; Werb Z
Genes Dev; 2018 Feb; 32(3-4):244-257. PubMed ID: 29483153
[TBL] [Abstract][Full Text] [Related]
22. The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptake.
Tuncel M; Aydin D; Yaman E; Tazebay UH; Güç D; Doğan AL; Taşbasan B; Uğur O
Cancer Biother Radiopharm; 2007 Apr; 22(2):281-8. PubMed ID: 17600477
[TBL] [Abstract][Full Text] [Related]
23. In IGF-I receptor-deficient leiomyosarcoma cells autocrine IGF-II induces cell invasion and protection from apoptosis via the insulin receptor isoform A.
Sciacca L; Mineo R; Pandini G; Murabito A; Vigneri R; Belfiore A
Oncogene; 2002 Nov; 21(54):8240-50. PubMed ID: 12447687
[TBL] [Abstract][Full Text] [Related]
24. Discoidin domain receptor 1 (DDR1), a promising biomarker, induces epithelial to mesenchymal transition in renal cancer cells.
Song J; Chen X; Bai J; Liu Q; Li H; Xie J; Jing H; Zheng J
Tumour Biol; 2016 Aug; 37(8):11509-21. PubMed ID: 27020590
[TBL] [Abstract][Full Text] [Related]
25. Up-regulation of insulin/insulin-like growth factor-I hybrid receptors during differentiation of HT29-D4 human colonic carcinoma cells.
Garrouste FL; Remacle-Bonnet MM; Lehmann MM; Marvaldi JL; Pommier GJ
Endocrinology; 1997 May; 138(5):2021-32. PubMed ID: 9112401
[TBL] [Abstract][Full Text] [Related]
26. Down-Regulation of DDR1 Induces Apoptosis and Inhibits EMT through Phosphorylation of Pyk2/MKK7 in DU-145 and Lncap-FGC Prostate Cancer Cell Lines.
Azizi R; Fallahian F; Aghaei M; Salemi Z
Anticancer Agents Med Chem; 2020; 20(8):1009-1016. PubMed ID: 32275493
[TBL] [Abstract][Full Text] [Related]
27. Decorin differentially modulates the activity of insulin receptor isoform A ligands.
Morcavallo A; Buraschi S; Xu SQ; Belfiore A; Schaefer L; Iozzo RV; Morrione A
Matrix Biol; 2014 Apr; 35():82-90. PubMed ID: 24389353
[TBL] [Abstract][Full Text] [Related]
28. Low Oxygen Tension Modulates the Insulin-Like Growth Factor-1 or -2 Signaling via Both Insulin-Like Growth Factor-1 Receptor and Insulin Receptor to Maintain Stem Cell Identity in Placental Mesenchymal Stem Cells.
Youssef A; Han VK
Endocrinology; 2016 Mar; 157(3):1163-74. PubMed ID: 26760116
[TBL] [Abstract][Full Text] [Related]
29. Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma.
Avnet S; Sciacca L; Salerno M; Gancitano G; Cassarino MF; Longhi A; Zakikhani M; Carboni JM; Gottardis M; Giunti A; Pollak M; Vigneri R; Baldini N
Cancer Res; 2009 Mar; 69(6):2443-52. PubMed ID: 19258511
[TBL] [Abstract][Full Text] [Related]
30. Diversity of insulin and IGF signaling in breast cancer: Implications for therapy.
Lero MW; Shaw LM
Mol Cell Endocrinol; 2021 May; 527():111213. PubMed ID: 33607269
[TBL] [Abstract][Full Text] [Related]
31. Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR.
Denley A; Bonython ER; Booker GW; Cosgrove LJ; Forbes BE; Ward CW; Wallace JC
Mol Endocrinol; 2004 Oct; 18(10):2502-12. PubMed ID: 15205474
[TBL] [Abstract][Full Text] [Related]
32. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
[TBL] [Abstract][Full Text] [Related]
33. Selective response to insulin versus insulin-like growth factor-I and -II and up-regulation of insulin receptor splice variant B in the differentiated mouse mammary epithelium.
Berlato C; Doppler W
Endocrinology; 2009 Jun; 150(6):2924-33. PubMed ID: 19246539
[TBL] [Abstract][Full Text] [Related]
34. Expression of insulin receptor (IR) A and B isoforms, IGF-IR, and IR/IGF-IR hybrid receptors in vascular smooth muscle cells and their role in cell migration in atherosclerosis.
Beneit N; Fernández-García CE; Martín-Ventura JL; Perdomo L; Escribano Ó; Michel JB; García-Gómez G; Fernández S; Díaz-Castroverde S; Egido J; Gómez-Hernández A; Benito M
Cardiovasc Diabetol; 2016 Dec; 15(1):161. PubMed ID: 27905925
[TBL] [Abstract][Full Text] [Related]
35. Suppressing miR-199a-3p by promoter methylation contributes to tumor aggressiveness and cisplatin resistance of ovarian cancer through promoting DDR1 expression.
Deng Y; Zhao F; Hui L; Li X; Zhang D; Lin W; Chen Z; Ning Y
J Ovarian Res; 2017 Jul; 10(1):50. PubMed ID: 28743276
[TBL] [Abstract][Full Text] [Related]
36. Collagen I-DDR1 signaling promotes hepatocellular carcinoma cell stemness via Hippo signaling repression.
Xiong YX; Zhang XC; Zhu JH; Zhang YX; Pan YL; Wu Y; Zhao JP; Liu JJ; Lu YX; Liang HF; Zhang ZG; Zhang WG
Cell Death Differ; 2023 Jul; 30(7):1648-1665. PubMed ID: 37117273
[TBL] [Abstract][Full Text] [Related]
37. Overexpression of DDR1 Promotes Migration, Invasion, Though EMT-Related Molecule Expression and COL4A1/DDR1/MMP-2 Signaling Axis.
Xie X; He H; Zhang N; Wang X; Rui W; Xu D; Zhu Y
Technol Cancer Res Treat; 2020; 19():1533033820973277. PubMed ID: 33234027
[TBL] [Abstract][Full Text] [Related]
38. Tumor-extrinsic discoidin domain receptor 1 promotes mammary tumor growth by regulating adipose stromal interleukin 6 production in mice.
Sun X; Gupta K; Wu B; Zhang D; Yuan B; Zhang X; Chiang HC; Zhang C; Curiel TJ; Bendeck MP; Hursting S; Hu Y; Li R
J Biol Chem; 2018 Feb; 293(8):2841-2849. PubMed ID: 29298894
[TBL] [Abstract][Full Text] [Related]
39. A putative role for Discoidin Domain Receptor 1 in cancer chemoresistance.
Ambrogio C; Darbo E; Lee SW; Santamaría D
Cell Adh Migr; 2018; 12(4):394-397. PubMed ID: 29505315
[TBL] [Abstract][Full Text] [Related]
40. Differential activation of insulin receptor isoforms by insulin-like growth factors is determined by the C domain.
Denley A; Brierley GV; Carroll JM; Lindenberg A; Booker GW; Cosgrove LJ; Wallace JC; Forbes BE; Roberts CT
Endocrinology; 2006 Feb; 147(2):1029-36. PubMed ID: 16239300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
